Introductory Clinical Pharmacology, 12th Edition by Ford Test Bank 2025 Edition All Chapters Complete Answers

TestiBankiforiIntroductoryiClinicaliPharmacologyi12thiEditioniFord




Introductory Clinical
Pharmacology 12th Edition Ford
Test Bank

, TestiBankiforiIntroductoryiClinicaliPharmacologyi12thiEditioniFord




1. Ainursingiinstructoriisipreparingiaiteachingiplaniforiaigroupiofinursingistudentsiaboutiphar
macology.iWhenidescribingithisitopic,itheiinstructoriwouldifocusitheidiscussionioniwhichi
ofitheifollowingiasianiessentialiaspect?
A) Druginame
B) Drugiclass
C) Drugiaction
D) Drugisource
iAns:i CiFeedback

:
Pharmacologyiisitheistudyiofidrugsianditheiriactionionilivingiorganisms.iThus,ianiessentiali
aspectiofipharmacologyiisidrugiaction.iAniunderstandingiofitheidruginame,idrugiclass,iandi
drugisourceiisiimportant,ibutitheimosticriticaliaspectirelateditoipharmacologyiisihowitheidru
giactsiinitheibody.


2. Ainursingistudentiisipreparingitoiadministeriaiprescribedidrugitoiaipatient.iTheistudentirevi
ewsiinformationiaboutitheidrugiandiitsiactions.iWhichiofitheifollowingiwouldibeitheibestich
oiceiforiobtainingithisiinformation?iSelectiallithatiapply.
A) Nursingiinstructor
B) Nurseiassigneditoitheipatient
C) Clinicalidrugireference
D) Prescribingihealthicareiprovider
E) Clinicalipharmacist
iAns:i C,iE

Feedback:
Althoughitheinursingistudenticaniaskitheinursingiinstructor,itheinurseiassigneditoitheipatien
t,ianditheiprescribingihealthicareiprovideriforiinformationiaboutitheidrug,itheibestichoicesif
oridrugiinformationiwouldiincludeianiappropriateidrugireferenceianditheiclinicalipharmaci
st.


3. Whenidescribingitheivariousitypesiofimedicationsitoiaigroupiofinursingistudents,iainu
rsingiinstructoriwouldiidentifyiwhichiofitheifollowingiasiaisourceiforiderivingimedica
tions?iSelectiallithatiapply.
A) Plants
B) Syntheticisources
C) Mold
D) Minerals
E) AnimalsiAns
:i A,iB,iC,iD,iE
Feedback:
Medicationsiareiderivedifrominaturalisources,iforiexample,iplants,imolds,iminerals,iandiani
mals,iasiwelliasicreatedisyntheticallyiiniailaboratory.




Pagei 1

, TestiBankiforiIntroductoryiClinicaliPharmacologyi12thiEditioniFord




4. Whichiofitheifollowinginamesimayibeiassigneditoiaidrugiduringitheiprocessiofide
velopment?iSelectiallithatiapply.
A) Chemicaliname
B) Officialiname
C) Pharmacologiciname
D) Tradeiname
E) Nonproprietaryiname
iAns:i A,iB,iD,iE

Feedback:
Throughoutitheiprocessiofidevelopment,idrugsimayihaveiseveralinamesiassigneditoithemiin
cludingiaichemicaliname,iaigenerici(nonproprietary)iname,ianiofficialiname,iandiaitradeiori
brandiname.


5. Aidrugimayibeiclassifiedibyiwhichiofitheifollowing?iSelectiallithatiapply.
A) Theichemicalitypeiofitheidrug'siactiveiingredient
B) Theiwayitheidrugiisiuseditoitreatiaispecificicondition
C) Theigenericinameiofitheidrug
D) Theitradeinameiofitheidrug
E) Theinonproprietaryinameiofitheidrugi
Ans:i A,iB
Feedback:
Aidrugimayibeiclassifiedibyitheichemicalitypeiofitheiactiveiingredientioribyitheiwayiitiisiuse
ditoitreatiaiparticularicondition.iGeneric,itrade,iandinonproprietaryireferitoihowiaidrugiisina
med.


6. Aigroupiofinursingistudentsiareireviewingiinformationiaboutitheiprocessiofidrugidevelo
pmentiinitheiUnitediStates.iTheistudentsidemonstrateiunderstandingiofithisiprocessiwhe
nitheyiidentifyithatiwhichiofitheifollowingicategoriesiareiassignedibyitheiFoodiandiDrugi
Administrationitoinewlyiapprovedidrugs?iSelectiallithatiapply.
A) Metabolite
B) Noncontrolledisubstance
C) Prescription
D) Nonprescription
E) Controlledisubstance
iAns:i C,iD,iE

Feedback:
Onceidrugsiareiapprovediforiuse,itheiFDAiassignsitheidrugitoioneiofitheifollowingicategori
es:iprescription,inonprescription,ioricontrolledisubstance.iMetaboliteirefersitoitheiinactive
iformiofitheidrug.iNoncontrolledisubstanceiisiaitermithatiisinotiused.




Pagei 2

, TestiBankiforiIntroductoryiClinicaliPharmacologyi12thiEditioniFord




7. Whichiofitheifollowingiwouldibeimostiimportantiforitheinurseitoidoitoiensureitheisafeiusei
ofiprescriptionidrugsiinitheiinstitutionalisetting?iSelectiallithatiapply.
A) Administeringidrugs
B) Monitoringiclientsiforidrugieffects
C) Prescribingidrugs
D) Evaluatingiclientsiforitoxicieffects
E) Educatingiclients/
caregiversiaboutidrugsiAns:i A,iB,iD,iE
Feedback:
Initheiinstitutionalisetting,itheinurse'siroleitoiensureisafeiuseiofiprescriptionidrugsiincludesi
administeringidrugs,imonitoringidrugieffects,ievaluatingiforitoxicieffects,iandieducatingicl
ientsiandicaregiversiaboutidrugs.


8. Theinurseiisihelpingiaiclientireviewiaiprescriptionifromitheihealthicareiprovider.iWheniex
aminingitheiprescription,iwhichiofitheifollowingiwoulditheinurseiexpectitoifindidocument
ed?iSelectiallithatiapply.
A) Nameiofitheidrug
B) Dosageiofitheidrug
C) Routeiofidrugiadministration
D) Timesiofidrugiadministration
E) Licensediprescriber'sisignature
iAns:i A,iB,iC,iD,iE

Feedback:
Theiprescriptionimusticontainitheiclient'siname,itheinameiofitheidrug,itheidosage,itheimetho
dianditimesiofiadministration,ianditheisignatureiofitheilicensedihealthicareiprovideriprescri
bingitheidrug.


9. Afteriteachingiaigroupiofinursingistudentsiaboutinonprescriptionidrugs,itheinursingiinstru
ctorideterminesithatitheiteachingiwasisuccessfuliwhenitheistudentsiidentifyiwhichiofitheifo
llowing?iSelectiallithatiapply.
A) Theyirequireiailicensedihealthicareiprovider'sisignature.
B) Theyiareireferreditoiasiover-the-counteridrugs.
C) Theyicanibeitakeniwithoutiriskitoitheiclient.
D) Theyihaveicertainilabelingirequirements.
E) Theyishouldibeitakenionlyiasidirectedionitheilabel.i
Ans:i B,iD,iE
Feedback:
Nonprescriptionidrugsiareioftenireferreditoiasiover-the-
counteri(OTC)idrugs.iTheyidoinotirequireiaiprescriptioni(ailicensedihealthicareiprovider'sis
ignature)ibutidoinoticomeiwithoutiriskitoitheiclient.iTheifederaligovernmentihasiimposedila
belingirequirementsiofiOTCidrugsianditheyishouldionlyibeitakeniasidirectedionitheilabeliunl
essiunderitheisupervisioniofiaihealthicareiprovider.




Pagei 3